Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostrum Oil&gas Regulatory News (NOG)

Share Price Information for Nostrum Oil&gas (NOG)

Share Price is delayed by 15 minutes
Get Live Data
3.50    0.00 (0.00%)
Bid:
3.00
Ask:
4.00
Spread: 1.00 (33.333%)
Market Cap: £5.77m
NOG Live PriceLast checked at - London Stock Exchange

Intraday Nostrum Oil&gas Share Chart

Operational Update for 3Q and 9M 2025

31 Oct 2025 07:00

RNS Number : 5940F
Nostrum Oil & Gas PLC
31 October 2025
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

 

FOR IMMEDIATE RELEASE

 

 

London, 31 October 2025

 

 

Operational Update for the third quarter and nine months ended 30 September 2025

 

Nostrum Oil & Gas PLC (LSE: NOG) ("Nostrum", or the "Company" and together with its subsidiaries, the "Group"), an independent mixed-asset energy company with world-class gas processing facilities and export hub in north-west Kazakhstan, today announces its operational update for the third quarter and nine months ended 30 September 2025.

 

Viktor Gladun, Chief Executive Officer of Nostrum Oil & Gas, commented:

 

"Nostrum continues on path of reinforcing its commitment to robust leadership and strategic growth. In this context, I am pleased to welcome Nikolay Ivin as the new Chairman of the Board, bringing extensive corporate finance experience across emerging markets, and James Hart as an independent non-executive director.

 

During the first nine months of 2025, Nostrum delivered strong operational results despite a challenging environment marked by lower oil prices and the natural decline of our mature Chinarevskoye field. Total processed volumes during the first three quarters increased by 33% compared to the same period of 2024, which was mainly driven by the rampup of third-party feedstock. These results underscore our reliability and efficiency both as an operator and a business partner.

 

We are continuing a thorough analysis of various development scenarios of our Stepnoy Leopard asset, while advancing a well-structured workover and drilling programme at the Chinarevskoye field in line with our licence obligations. Alongside our continued focus on cost efficiency and disciplined capital deployment, these initiatives aim to create sustainable, long-term value for our shareholders, stakeholders, and the people of Kazakhstan."

 

9M 2025 Highlights:

 

Operational

· Production and sales

· A 33% increase in average processed volumes (including third party condensate tolling volumes) to 23,596 boepd in 9M 2025 (9M 2024: 17,748 boepd). An 18.5% increase in average daily titled production volumes (i.e. final products processed and owned by Nostrum) to 16,300 boepd in 9M 2025 (9M 2024: 13,758 boepd). These increases were achieved through continuing to process the ramping up feedstock from Ural Oil & Gas LLP ("Ural O&G"), and managing expected decline in Chinarevskoye production through well workovers.

· The titled production volume split was as follows:

Products

9M 2025

volumes

(boepd)

9M 2024

volumes

 (boepd)

Y-on-Y

Change

(%)

9M 2025

product mix

(%)

9M 2024

product mix

 (%)

Crude Oil

2,403

2,500

(3.9)%

14.7%

18.2%

Stabilised Condensate*

1,559

1,824

(14.5)%

9.6%

13.3%

LPG (Liquid Petroleum Gas)

3,038

2,335

30.1%

18.6%

17.0%

Dry Gas

9,300

7,099

31.0%

57.1%

51.5%

Total

16,300

13,758

18.5%

 

100.0%

100.0%

*Stabilised condensate volumes exclude Ural O&G processed volumes for which Nostrum receives a fixed tolling fee

 

· A 19.9% increase in average daily sales volumes to 14,339 boepd in 9M 2025 (9M 2024: 11,956 boepd), reflecting the increase in titled production. The difference between titled production and sales volumes is primarily due to the internal consumption of dry gas produced and timing of product deliveries, which may lead to inventory increases or decreases at period end.

 

· Chinarevskoye drilling and workover programme

The Company's Chinarevskoye limited-scale drilling programme for 2025 targets most economic subsurface opportunities while also ensuring compliance with license obligations. On 13 October 2025, the Company successfully completed drilling operations on the well No.116_1, which is followed by well completion and testing over the following four to six weeks. In parallel, the Company continues to carry out optimised well workovers to minimise production decline and enhance operational efficiency.

· Stepnoy Leopard Fields

In April 2025, the Company received formal approval from Kazakhstan's Ministry of Energy for a phased Full-Field Development Plan (FDP) for the Stepnoy Leopard Fields. The Company is actively progressing with detailed design and engineering activities, alongside selective procurement, to ensure compliance with license commitments. Key development projects, including the pipeline to Chinarevskoye and the sour gas treatment infrastructure, are currently undergoing rigorous review to ensure alignment with project objectives and regulatory requirements.

· Processing of Ural O&G products

 

Throughout 9M 2025, the Company continued processing raw gas and condensate volumes from Ural O&G, resulting in the increases in titled production and processed volumes. On 8 October 2025, processing volumes from Ural Oil & Gas achieved a record high. As announced on 21 March 2025, the Company signed a new agreement with Ural Oil & Gas, extending third-party hydrocarbon processing terms through May 2031, strengthening cash flows, supporting efficient plant operations, and facilitating cost-effective development of the Rozhkovskoye field.

 

Financial

· 9M 2025 revenue is estimated to be approximately US$85.5 million (9M 2024: US$101.4 million). The increase in titled production and processed volumes from Ural O&G feedstock and a continued well workover had a positive impact on revenues. However, this was offset by a less favorable product mix of higher-value oil and stabilized condensate products, along with a natural decline in production at the Chinarevskoye field and a 14% decrease in the average Brent crude oil price (US$70.95/bbl in 9M 2025 vs US$82.6/bbl in 9M 2024).

 

· The unrestricted cash and cash equivalents balance as at 30 September 2025 was in excess of US$147.3 million (30 June 2025: US$135.9 million, 31 December 2024: US$150.4 million). The restricted cash balance (debt service retention account ("DSRA") and asset liquidation fund) was in excess of US$26.2 million as at 30 September 2025 (30 June 2025: US$26.1 million, 31 December 2024: US$25.9 million).

 

· In 9M 2025, the Group generated a positive net operating cashflow of approximately US$21.8 million before one-off items. After the limited capital expenditures on the Chinarevskoye and Stepnoy Leopard fields and one-off payments under the management incentive plan the Group's unrestricted cash and cash equivalents balance reduced by approximately US$3.0 million during 9M 2025.

 

· The Group remains focused on maximising facility uptime with the annual plant maintenance completed earlier than planned, controlling costs wherever possible, and improving efficiencies across all facets of business. At the same time, we are committed to allocating and utilising resources efficiently to support our growth projects.

 

HSE and ESG

· Zero fatalities among employees and contractors during operations in 9M 2025 (9M 2024: zero).

 

· Total Recordable Incidents Rate (incidents per million man-hours) of 0.81 in 9M 2025 (9M 2024:0.84).

 

· Zero Lost Time Injury Rate (incidents per million man-hours) in 9M 2025 (9M 2024: zero).

 

· 3,087 tonnes of air emissions emitted in 9M 2025 against 5,188 tonnes permitted for 2025 under the Kazakhstan Environmental Code.

 

· Safety of all staff and contractors, along with a commitment to sustainable operations, remains the Group's priority.

 

Release of Nostrum's 9M 2025 Financial Results

Nostrum plans to release its unaudited interim condensed consolidated accounts for the period ending 30 September 2025 on or around 25 November 2025.

 

 

LEI: 2138007VWEP4MM3J8B29

 

Further information

For further information please visit www.nostrumoilandgas.com

 

Further enquiries

Nostrum Oil & Gas PLC

Elena Zhuravleva

Chief Financial Officer

ir@nog.co.uk

 

Instinctif Partners - UK

Galyna Kulachek

+ 44 (0) 207 457 2020

nostrum@instinctif.com

 

Notifying person

Thomas Hartnett

Company Secretary

 

 

About Nostrum Oil & Gas

Nostrum Oil & Gas PLC is an independent mixed-asset energy company with world-class gas processing facilities and export hub in north-west Kazakhstan. Its shares are listed on the London Stock Exchange (ticker symbol: NOG). The principal producing asset of Nostrum Oil & Gas PLC is the Chinarevskoye field which is operated by its wholly-owned subsidiary Zhaikmunai LLP, which is the sole holder of the subsoil use rights with respect to the development of the Chinarevskoye field. The Company also owns an 80% interest in Positiv Invest LLP, which holds the subsoil use rights for the "Kamenskoe" and "Kamensko-Teplovsko-Tokarevskoe" areas in the West Kazakhstan region (the Stepnoy Leopard fields).

 

Forward-Looking Statements

Some of the statements in this document are forward-looking. Forward-looking statements include statements regarding the intent, belief and current expectations of the Company or its officers with respect to various matters. When used in this document, the words "expects", "believes", "anticipates", "plans", "may", "will", "should" and similar expressions, and the negatives thereof, are intended to identify forward-looking statements. Such statements are not promises nor guarantees and are subject to risks and uncertainties that could cause actual outcomes to differ materially from those suggested by any such statements.

 

No part of this announcement constitutes, or shall be taken to constitute, an invitation or inducement to invest in the Company or any other entity, and shareholders of the Company are cautioned not to place undue reliance on the forward-looking statements. Save as required by the relevant listing rules and applicable law, the Company does not undertake to update or change any forward-looking statements to reflect events occurring after the date of this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFFFLLIRLIVIE
Date   Source Headline
1st Jun 20267:00 amRNSPublication of Annual Report and Notice of AGM
26th May 20267:09 amRNS1st Quarter Results
14th May 202610:59 amRNSUpdate re Kazakhstan withholding tax disputes
7th May 20265:11 pmRNSBoard Change
30th Apr 20267:00 amRNSOperational Update for Q1 ended 31 March 2026
29th Apr 20267:00 amRNSFull Year Results
30th Mar 202611:38 amRNSProposed Transaction
17th Feb 202611:51 amRNSFurther update on Kazakhstan withholding tax
9th Feb 20269:17 amRNS-RUpdate re Kazakhstan withholding tax disputes
9th Feb 20267:00 amRNSBoard Committee Changes
3rd Feb 20269:38 amRNS-RUpdate on Kazakhstan withholding tax disputes
30th Jan 20267:00 amRNSOperational Update for Q4 and FY2025
26th Jan 202612:18 pmRNSBoard Change
2nd Jan 20268:30 amRNSNotice of delayed interest payments on notes
19th Dec 20255:02 pmRNSFurther statement in relation to AGM vote
19th Dec 20255:02 pmRNSFurther statement in relation to AGM vote
25th Nov 20257:00 amRNSFinancial results for Q3 and 9M 2025
21st Nov 20257:00 amRNSAppointment of NED and Board Committee Changes
31st Oct 202511:27 amRNSBoard Committee Change
31st Oct 20257:00 amRNSOperational Update for 3Q and 9M 2025
24th Oct 20257:00 amRNSAppointment of a NED and Board Committee Changes
17th Oct 20257:00 amRNSAppointment of Nikolay Ivin as Chairman
6th Oct 202510:57 amRNSConsent Solicitation Results
24th Sep 202510:02 amRNSConsent Solicitation
19th Sep 202512:38 pmRNSNew CFO
16th Sep 20254:35 pmRNSConsent solicitation results at early consent date
16th Sep 20253:40 pmRNSMaterial related party transaction and new COO
2nd Sep 20255:23 pmRNSConsent solicitation re payment delay on notes
29th Aug 20257:00 amRNSFinancial results for Q2 and 6M ended 30 June 2025
31st Jul 20257:00 amRNSOperational Update for Q2 and H1 2025
30th Jul 20259:19 amRNSUpdate: delayed interest payments,proposed actions
22nd Jul 20253:33 pmRNSUpdate: delayed interest payments,proposed actions
15th Jul 20255:37 pmRNSAppointment of CEO and a Non-Executive Director
10th Jul 202511:38 amRNSNotification of delayed interest payments
30th Jun 20251:48 pmRNSStakeholder discussions and Board changes
30th Jun 202512:18 pmRNSResult of AGM
6th Jun 202511:43 amRNSPublication of Annual Report and Notice of AGM
20th May 20257:00 amRNS1st Quarter Results
30th Apr 20257:00 amRNSOperational Update for Q1 2025
25th Apr 20253:25 pmRNS2024 Report on Payments to Governments
23rd Apr 20257:00 amRNSFull Year Results
10th Apr 20253:20 pmRNSTR-1: Notification of major holdings
7th Apr 20258:41 amRNSShares Cancellation, Change in Total Voting Rights
4th Apr 20257:00 amRNSApproval of Stepnoy Leopard Field Development Plan
21st Mar 20257:00 amRNSProcessing Agreement extension with Ural Oil & Gas
6th Feb 202511:52 amRNSHolding(s) in Company
31st Jan 20257:00 amRNSOperational Update for Q4 and FY2024
12th Dec 202412:01 pmRNSHolding(s) in Company
2nd Dec 20244:17 pmRNSPurchase and Cancellation of Deferred Shares
19th Nov 20247:00 amRNSFinancial Results for Q3 and 9M 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.